Cargando…

Auditory Evoked P300 Potential in Patients With Parkinson’s Disease

Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Though the cardinal features of PD are motor symptoms, it is also associated with many non-motor symptoms, such as cognitive impairment, autonomic dysfunction, sleep disorders, and depression, which could affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendran, Dhivya, Bandhu, Rajiv, Gautam, Sujata, K. Dhamija, Rajinder, Mondal, Sunita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599456/
https://www.ncbi.nlm.nih.gov/pubmed/37885554
http://dx.doi.org/10.7759/cureus.45933
_version_ 1785125768668381184
author Rajendran, Dhivya
Bandhu, Rajiv
Gautam, Sujata
K. Dhamija, Rajinder
Mondal, Sunita
author_facet Rajendran, Dhivya
Bandhu, Rajiv
Gautam, Sujata
K. Dhamija, Rajinder
Mondal, Sunita
author_sort Rajendran, Dhivya
collection PubMed
description Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Though the cardinal features of PD are motor symptoms, it is also associated with many non-motor symptoms, such as cognitive impairment, autonomic dysfunction, sleep disorders, and depression, which could affect the quality of life. Early identification of PD's non-motor signs can aid in the diagnosis of PD. The current research aimed to assess the neurophysiological changes in PD patients using auditory evoked P300 potential and to determine the possible correlation between P300 wave components and cognitive impairment. Materials and methods: This cross-sectional research involved 32 idiopathic PD patients. The neurophysiological changes in PD patients were studied using auditory evoked P300 potential and the obtained data were compared with normative data. The patient’s cognitive status was scored using the Montreal Cognitive Assessment (MoCA) questionnaire and they were divided into two groups: the patients with normal cognition and the patients with impaired cognition. Results: The participants showed a significant decrease in P300 amplitude (p = 0.000) but no change in P300 latency when compared to normative data using the Wilcoxon rank sum test. Also, there was a positive correlation between the MoCA score and P300 amplitude (p < 0.05), indicating that if cognition is impaired, P300 amplitude would also be reduced. There was a significant difference between PD patients with impaired cognition and patients with normal cognition in the P300 amplitude at Cz (p = 0.001) and Fz (p = 0.003) when the Mann-Whitney U test was used. These findings indicate that it is possible to notice changes in the P300 wave components among PD patients when their cognition is impaired. Conclusion: Auditory evoked P300 potentials can be used to objectively evaluate cognition in PD patients and by starting supportive therapy, the quality of life for PD patients can be improved.
format Online
Article
Text
id pubmed-10599456
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105994562023-10-26 Auditory Evoked P300 Potential in Patients With Parkinson’s Disease Rajendran, Dhivya Bandhu, Rajiv Gautam, Sujata K. Dhamija, Rajinder Mondal, Sunita Cureus Other Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Though the cardinal features of PD are motor symptoms, it is also associated with many non-motor symptoms, such as cognitive impairment, autonomic dysfunction, sleep disorders, and depression, which could affect the quality of life. Early identification of PD's non-motor signs can aid in the diagnosis of PD. The current research aimed to assess the neurophysiological changes in PD patients using auditory evoked P300 potential and to determine the possible correlation between P300 wave components and cognitive impairment. Materials and methods: This cross-sectional research involved 32 idiopathic PD patients. The neurophysiological changes in PD patients were studied using auditory evoked P300 potential and the obtained data were compared with normative data. The patient’s cognitive status was scored using the Montreal Cognitive Assessment (MoCA) questionnaire and they were divided into two groups: the patients with normal cognition and the patients with impaired cognition. Results: The participants showed a significant decrease in P300 amplitude (p = 0.000) but no change in P300 latency when compared to normative data using the Wilcoxon rank sum test. Also, there was a positive correlation between the MoCA score and P300 amplitude (p < 0.05), indicating that if cognition is impaired, P300 amplitude would also be reduced. There was a significant difference between PD patients with impaired cognition and patients with normal cognition in the P300 amplitude at Cz (p = 0.001) and Fz (p = 0.003) when the Mann-Whitney U test was used. These findings indicate that it is possible to notice changes in the P300 wave components among PD patients when their cognition is impaired. Conclusion: Auditory evoked P300 potentials can be used to objectively evaluate cognition in PD patients and by starting supportive therapy, the quality of life for PD patients can be improved. Cureus 2023-09-25 /pmc/articles/PMC10599456/ /pubmed/37885554 http://dx.doi.org/10.7759/cureus.45933 Text en Copyright © 2023, Rajendran et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Other
Rajendran, Dhivya
Bandhu, Rajiv
Gautam, Sujata
K. Dhamija, Rajinder
Mondal, Sunita
Auditory Evoked P300 Potential in Patients With Parkinson’s Disease
title Auditory Evoked P300 Potential in Patients With Parkinson’s Disease
title_full Auditory Evoked P300 Potential in Patients With Parkinson’s Disease
title_fullStr Auditory Evoked P300 Potential in Patients With Parkinson’s Disease
title_full_unstemmed Auditory Evoked P300 Potential in Patients With Parkinson’s Disease
title_short Auditory Evoked P300 Potential in Patients With Parkinson’s Disease
title_sort auditory evoked p300 potential in patients with parkinson’s disease
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599456/
https://www.ncbi.nlm.nih.gov/pubmed/37885554
http://dx.doi.org/10.7759/cureus.45933
work_keys_str_mv AT rajendrandhivya auditoryevokedp300potentialinpatientswithparkinsonsdisease
AT bandhurajiv auditoryevokedp300potentialinpatientswithparkinsonsdisease
AT gautamsujata auditoryevokedp300potentialinpatientswithparkinsonsdisease
AT kdhamijarajinder auditoryevokedp300potentialinpatientswithparkinsonsdisease
AT mondalsunita auditoryevokedp300potentialinpatientswithparkinsonsdisease